I ask the question. Why should i not be entitled to be interested in ADO?
I will give you half a clue why i am. I held the stock for around 3 plus years and have read the majority of posts ramping and hyping up the ADO IP. Guess what! none of it came to fruition. As one who sold out entirely between 25 cents and 12 cents I continue to look on and read with interest about what a diabolical stuff up this company has turned into.
Some of you mob here on HC have been constantly grizzling about the stuff ups and blaming this one and that one. I reckon it might be prudent to question the commercial viability of the IP as not even the people who developed it can manage to sell it.
Give Matt Sanderson a go because he successfully promoted ADO on the strength of M&G to many posters on here over the years. I reckon he will have the incentive to get this going. Let us see how good he is at selling something that no one else has managed to do for the last 7 years. Tough times ahead in my opinion.
- Forums
- ASX - By Stock
- ADO
- Ann: Anteo Files its Battery Patent in Key Lithium-ion Markets
Ann: Anteo Files its Battery Patent in Key Lithium-ion Markets, page-32
-
- There are more pages in this discussion • 356 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.83M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $12.86K | 585.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 371875 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 291569 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 371875 | 0.021 |
13 | 2204550 | 0.020 |
8 | 2890767 | 0.019 |
10 | 1652665 | 0.018 |
3 | 94160 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 291569 | 3 |
0.023 | 864053 | 6 |
0.024 | 1306228 | 3 |
0.025 | 214144 | 4 |
0.027 | 680612 | 2 |
Last trade - 14.06pm 15/07/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online